Venetoclax yog nyob rau hauv cov tshuaj hu ua B-cell lymphoma-2 (BCL-2) inhibitors. Nws ua haujlwm los ntawm kev thaiv qhov kev txiav txim ntawm qee yam protein hauv lub cev uas pab cov qog nqaij hlav cancer ciaj sia. Qhov no pab tua cov qog nqaij hlav cancer.
Yuav ua li cas thaum koj noj Venetoclax?
Kev noj Venclexta tuaj yeem ua teeb meem nrog koj cov ntshav suav. Neutropenia (cov qe ntshav dawb tsawg) yog cov ntshav tsis txaus uas tuaj yeem tshwm sim nrog Venclexta. Nws ua rau koj muaj kev pheej hmoo kis kab mob, uas qee zaum tuaj yeem loj lossis tuag taus.
Puas Venetoclax puas yog tshuaj khomob?
Chemotherapy tshuaj, xws li venetoclax, ua haujlwm sib txawv los tiv thaiv kev loj hlob ntawm cov qog nqaij hlav cancer, los ntawm kev tua cov hlwb, los ntawm kev txwv tsis pub faib, lossis los ntawm kev tso tseg. los ntawm kev sib kis.
Koj tuaj yeem noj Venetoclax ntev npaum li cas?
Koj tseem yuav noj VENCLEXTA ib zaug ib hnub kom txog rau thaum kawg ntawm 12 lub hlis kho. VENCLEXTA yuav tsum tau noj ntawm cov tshuaj noj txhua hnub raws li tau hais tseg kom txog thaum koj tus kws kho mob qhia koj kom tsis txhob noj VENCLEXTA lossis hloov koj cov koob tshuaj.
Yuav ua li cas yog qhov kev txiav txim ntawm Venetoclax?
Mechanism of action
Venetoclax yog BH3-mimetic. Venetoclax blocks anti-apoptotic B-cell lymphoma-2 (Bcl-2) protein, ua rau cov txheej txheem cell tuag ntawm CLL hlwbTshaj tawm ntawm Bcl-2 hauv qee cov qog ntshav qog ntshav tau txuas rau nce tsis kam mus rau chemotherapy.
